Investments range between EUR 2 million and EUR 12 million
LSP Dementia seeks to invest in innovative companies focusing on neurodegenerative diseases with dementia, that have products or technologies that target underlying neurodegenerative processes or its symptoms and signs. LSP Dementia’s geographical focus is primarily Europe, but Asia, Israel and the USA are certainly also of interest.
LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands
Company Registration Number: 34296447
LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.
- SizeEUR 275 m
- SFDR classificationArt. 8
Investment advisory committee
- ChairpersonProf. dr Huibert Pols, emiritus Professor of Internal Medicine
- CountryUnited Kingdom
- Muna Therapeutics
- New Amsterdam Pharma